Download Publikationer R Bränström 2014

PUBLIKATIONSFÖRTECKNING
1. HellströmPM,BränströmR,Al‐SaffarA.Computerprogram”MMC”tosummerize
characteristics of activity fronts of migrating myoelectric complex in rat small
intestine.SurResComm14:51‐63,1993.
2. Brundin T, Bränström R, Wahren J. Effects of intravenous versus oral glucose
administered on oxygen consumption and blood flow in splanchnic and extra‐
splanchnictissues.AmJPhysiol34:E496‐E504,1996.
3. Bränström R, Hellström PM. Characteristics and fed myoelectric activity in rat
small intestine: evaluation by computer analysis. Acta Physiol Scand 158:53‐62,
1996.
4. LarssonO,DenneyJT,BränströmR,BerggrenP‐O,CorkeyBE.ActivationoftheATP
sensitiveK+‐channelbylongchainacyl‐CoA:Aroleinmodulationofpancreaticβ‐
cell.JBiolChem271:10623‐10626,1996.
5. Larsson O, Kindmark H, Bränström R, Fredholm B, Berggren P‐O. Oscillations in
KATPchannelactivitypromotesoscillationsincytoplasmicfreeCa2+concentration
inthepancreaticβ‐cell.ProcNatlAcadSciUSA93:5161‐5165,1996.
6. SelldenE,BränströmR,BrundinT.Preoperativeinfusionofaminoacidsprevents
postopertivehypothermia.BrJAnaesthesia76:227‐234,1996.
7. Sellden E, Bränström R, Brundin T. Augumented thermic effects of amino acids
under general anaesthesia occurs predominantly in extra‐splanchnic tissues. Clin
Science91:431‐439,1996.
8. BränströmR,CorkeyBE,BerggrenP‐O,LarssonO.Evidenceforauniquelongchain
acyl‐CoA ester binding site on the ATP‐regulated potassium channel in mouse
pancreaticbetacells.JBiolChem272:17390‐17394,1997.
9. BränströmR,HöögA,WahlM,BerggrenP‐O,LarssonO.RIN14B–Apancreaticδ‐
celllinemaintaningATPdependentK+channelsbutdedifferentiatedwithregardto
somatostatinsecretion.FEBSLetters411:301‐307,1997.
10. SelldenE,BrundinT,BränströmR,WahrenJ.Effectsofaminoacidinfusiononbody
temperatureduringanaesthesia.BrJAnaesthesia78:339,1997.
1
11. BrownH,LarssonO,BränströmR,YangSN,LeibigerB,LeibigerI,FriedG,MoedeT,
Deeney JT, Brown GR, Jacobsson G, Rhodes CJ, Braun JE, Scheller RH, Corkey BE,
Berggren PO, Meister B. Cysteine string protein (CSP) is an insulin secretory
granuleassociatedproteinregulatingβ‐cellexocytosis.EMBOJ17:5048‐5058,1998.
12. BränströmR,EfendicS,BerggrenPO,LarssonO.Directinhibitionofthepancreatic
β‐ cell ATP‐regulated potassium by α‐ketoisocaproate. J Biol Chem 273:14113‐
14118,1998.
13. Bränström R, Leibiger IB, Leibiger B, Corkey BE, Berggren PO, Larsson O. Long
chain coenzyme A esters activate the pore‐forming subunit (Kir6.2) of the ATP‐
regulatedpotassiumchannel.JBiolChem273:31395‐313400,1998.
14. Lördal M, Bränström R, Hellström PM. Mediation of irregular spiking activity by
multiple neurokinin‐receptors in the small intestine of the rat. Br J Pharmacol
123:63‐70,1998.
15. YangSN,LarssonO,BränströmR,BertorelloAM,LeibigerB,LeibigerIB,MoedeT,
Köhler M, Meister B, Berggren PO. Syntaxin 1 interacts with the L(D) subtype of
voltage‐gated Ca(2+) channels in pancreatic beta cells. Proc Natl Acad Sci USA
96:10164‐10169,1999.
16. EfanovAM,HoyM,BränströmR,ZaitsevSV,MagnusonMA,EfendicS,GromadaJ,
BerggrenPO.TheimidazolineRX871024stimulatesinsulinsecretioninpancreatic
beta‐cellsfrommicedeficientinK(ATP)channelfunction.BBRC284:918‐922,2001.
17. Kindmark H, Köhler M, Brown G, Bränström R, Larsson O, Berggren PO. Glucose
inducedoscillationsincytoplasmicfreeCa2+‐concentrationinthepancreaticβ‐cell
are not preceded by oscillations in mitochondrial membrane potential. JBiolChem
276:34530‐34536,2001.
18. Kindmark, H, Köhler M, Brown G, Bränström R, Larsson O, Berggen PO. Glucose
inducedoscillationsincytoplasmicfreeCa2+concentrationprecedeoscillationsin
mitochondrial membrane potential in the pancreatic beta‐cell. J Biol Chem
276:44356‐44356,2001.
19. Efanov AM, Appelskog IB, Abdel‐Halim SM, Khan A, Bränström R, Larsson O,
ÖstensonCG,MestHJ,BerggrenPO,EfendicS,ZaitsevSV.Insulinotropicactivityof
theimidazolinederivativeRX871024inthediabeticGKrat.Am.JPhysiol282:E117‐
E124,2002.
2
20. Välimäki S, Höög A, Larsson C, Farnebo LO, BränströmR. High extracellular Ca2+
hyperpolarizeshumanparathyroidcellsviaCa2+‐activatedK+channels.JBiolChem
278:49685‐49690,2003.
21. Bränström R, Aspinwall CA, Välimäki S, Östensson C‐G, Tibell A, Eckhard M,
BrandhorstH,CorkeyBE,BerggrenP‐O,LarssonO.Effectsoflong‐chainCoAesters
on KATP channel activity in human pancreatic beta‐cell: Potential role in type 2
diabetes.Diabetologia47:277‐283,2004.
22. Bäck M, Bu D‐X, Bränström R, Sheikine Y, Yan Z‐Q, Hansson GK. Leukotriene B4
signaling through NF‐κB‐dependent BLT1 receptors on vascular smooth muscle
cellsinatherosclerosisandintimalhyperplasia.Proc.Natl.Acad.Sci.USA29:17501‐
17506,2005.
23. BränströmR,LeibigerIB,LeibigerB,KlementG,NilssonJ,ÅrhemP,AspinwallCA,
Corkey BE, Larsson O, Berggren PO. Single residue (K332A) substitution in Kir6.2
abolishesthestimulatoryeffectoflong‐chainacyl‐CoAesters:indicationsforalong
chainacyl‐CoAesterbindingmotif.Diabetologia50:1670‐1677,2007.
24. Juhlin CC, Villablanca A, Sandelin K, Haglund F, Nordenström J, Forsberg L,
Bränström R, Guiters G, Obara T, Arnolds A, Larsson C, Höög A. Parafibromin
immunoreactivity ‐ its use as an additional diagnostic marker for parathyroid
tumourclassification.EndocRelCan14:501‐512,2007.
25. Deeney J, Bränström R, Corkey BE, Larsson O, Berggren PO. 3H‐Serotonin as a
Marker of Oscillatory Insulin Secretion in Clonal ß‐Cells (INS‐1). FEBS Letters
581:4080‐4084,2007.
26. Lu M, Forsberg L, Höög A, Juhlin CC, Larsson C, Conigrave AD, Delbrigde L, Gill A,
Bark C, Farnebo LO, Bränström R. Heterogeneous expression of SNARE proteins
SNAP‐23, SNAP‐25, Syntaxin1 and VAMP in human parathyroid tissue. Mol Cell
Endoc287:72‐80,2008.
27. ZhangF,DeyD,BränströmR,ForsbergL,LuM,ZhangQ,SjöholmÅ.BLX‐1002,a
novel thiazolidinedione with no PPAR affinity, stimulates AMP‐activated protein
kinase activity, raises cytosolic Ca2+, and enhances glucose stimulated insulin
secretioninaPI3K‐dependentmanner.AmJPhysiology296:C346‐C354,2009.
3
28. JuhlinCC,HaglundF,VillablancaA,ForsbergL,SandelinK,BränströmR,LarssonC,
Höög A. Loss of expression for the Wnt pathway components adenomatous
polyposiscoliandglycogensynthasekinase3‐betainparathyroidcarcinomas.IntJ
Oncol34:481‐492,2009.
29. LuM,BränströmR,BerglundE,HöögA,BjörklundP,WestinG,LarssonC,Farnebo
LO,ForsbergL.ExpressionandassociationofTRPCsubtypeswithOrai1andSTIM1
inhumanparathyroid.J.Mol.Endo.44:285‐294,2010.
30. BränströmR,BerglundE,CurmanP,ForsbergL,HöögA,GrimeliusL,BerggrenPO,
Mattson P, Hellman P, Juntti‐Berggren L. Electrical short‐circuit in ‐cells from a
patient with non‐insulinoma pancreatogenous hypoglycemic syndrome (NIPHS): a
casereport.JMedCaseRep4:315,2010.
31. Lu M, Berglund E, Larsson C, Höög A, Farnebo LO, Bränström R. Calmodulin and
calmodulin‐dependent protein kinas II (CaMKII) inhibit hormone secretion in
humanparathyroidadenoma.JEndoc.208:31‐39,2011.
32. MaZ,LavebrattC,AlmgrenM,PortwoodN,ForsbergLE,BränströmR,BerglundE,
FalkmerS,SundlerF,WierupN,BjörklundA.Evidenceforpresenceandfunctional
effects of Kv1.1 channels in beta‐cells: General survey and results from
mceph/mcephmice.PLoSOne6:e18213,2011
33. Haglund F, Lu M, Vukojevic V, Nilsson IL, Andreasson A, Dzabic M, Bränström R,
HöögA,JuhlinCC,LarssonC.ProlactinReceptorinPrimaryHyperparathyroidism–
Expression,FunctionalityandClinicalCorrelations.PLoSOne7:36448,2012.
34. Åhlen J, Westerdahl J, Zedenius J, BränströmR, Larsson C, Nilsson IL. Side‐effects
from imatinib treatment of advanced GIST–associated with a better outcome.
JournalofCancerTherapeutics&Research1,2012.
35. Berglund E, Berglund D, Akcakayam P, Ghaderi M, Dare E, Berggren PO, Aspinwall
CA, Lui WO, Zedenius J, Larsson C, Bränström R. Evidence for Calcium-Regulated
ATP Release in Gastrointestinal Stromal Tumors. Experimental Cell Research
319(8):1229-1238, 2013.
36. Lu M, Farnebo LO, Bränström R, Larsson C. Regulation of Parathyroid Hormone
Secretion by Caffeine in Human parathyroid cell. Journal of Clinical Endocrinology and
metabolism 98(8):1345-1351, 2013.
4
37. Berglund E, Ubhavasekera K, Karlsson F, Akcakaya P, Aluthgedara W, Åhlen J, Fröbom
R, Nilsson IL, Lui WO, Larsson C, Zedenius J, Bergkvist J, Bränström R. Intracellular
concentration of the tyrosine kinas inhibitor Imatinib in gastrointestinal stromal tumor
cells. Anticancer Drugs 25(4):415-422, 2014.
38. Berglund E, Akcakaya P, Berglund D, Karlsson F, Vukojević V, Lee L, Bogdanović D,
Lui WO, Larsson C, Zedenius J, Fröbom R, Bränström R. Function role of the Ca2+activated Cl- channel DOG1/TMEM16A in gastrointestinal stromal tumor cells.
Experimental Cell Research 2014, In press.
39. FlamB,BrooméM,FrenckerB,BränströmR,BellM.Pheochromocytoma‐Induced
Inverted Takotsubo‐Like Cardiomyopathy Leading to Cardiogenic Shock
SuccessfullyTreatedwithExtracorporealMembraneOxygenation.AcceptedJournal
ofIntensiveCareMedicine2014.
5